Just a month after getting approval for its new pneumococcal vaccine Vaxneuvance in adults ... the basis of regulatory filing to extend the label for Vaxneuvance later this year, according ...

Ligand Pharmaceuticals offers biotech exposure with reduced risk through its royalty platform. Discover why its valuation now ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

An important step is getting pneumococcal vaccination if it's recommended for you. This vaccine helps protect against pneumococcal disease, including, pneumococcal pneumonia, bloodstream infection ...

Merck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), Capvaxive, for the prevention of invasive pneumococcal disease ...

EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults “Pneumococcal disease continues to pose a significant risk for adults in Europe, among adults who are ...

Merck & Co – known as MSD outside the US and Canada – has announced that its adult-specific 21-valent pneumococcal conjugate vaccine has been approved by the European Commission (EC). The vaccine, ...

A lack of vaccination against respiratory pathogens was commonly identified among US international travelers, indicating the need to improve vaccine uptake at pre-travel visits.

Amid the growing importance of pneumococcal vaccination to prevent pneumonia during the change of seasons, confusion is ...

Merck, known as MSD outside of the United States and Canada, announced that the European Commission (EC) has approved Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) for active immunization for ...